- TRADE NAME: Vaxchora (PaxVax)
- INDICATIONS: Immunization against cholera for adults traveling to cholera-affected areas
- CLASS: Vaccine
- HALF-LIFE: N/A
- FDA APPROVAL DATE: 06/10/2016
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Antibiotics, Chloroquine - PREGNANCY: Not expected to cause fetal risk
Please login to view the rest of this drug profile.
Page last updated 07/31/2023